Delivery Order SPE2DB24D1007-SPE2DB25FCCNC
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $5,346.26 delivery order to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, indicating it is issued under a larger indefinite delivery contract (IDC) vehicle. The pharmaceutical product will be delivered to the...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $6,450.70 and issued by the Defense Logistics Agency (DLA). The contract is for the delivery of the pharmaceutical product Dapagliflozin 5 mg Tablet, a medication used to treat type 2 diabetes. The order has a firm fixed-price pricing type and an ultimate completion date of September 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a $1,224.71 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,840 units of dapagliflozin 10 mg tablets. The contract has a period of performance through September 18, 2024 and was awarded on September 17, 2022. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,941,013 units of Dapagliflozin 10 mg tablets, a prescription medication. The order has a ceiling value of $3,969.09 and a completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC)...
- This is a $3,480.97 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Dapagliflozin 10 mg tablets. The contract has an ultimate completion date of June 12, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp Corporate Office Division. The $4,295.42 firm-fixed-price delivery order is for the supply of 4565406421 dapagliflozin 10 mg tablets in 30-count packages. The contract has an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,296,475 units of the pharmaceutical product Dapagliflozin 10 mg Tablet in 30-count packages. The fixed-price contract has a ceiling value of $29,210.27 and a completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,406.23 firm fixed-price contract is for the supply of 4,565,693,581 units of the pharmaceutical product dapagliflozin 10 mg tablets. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,274.86 firm fixed-price contract is for the delivery of 4,565,614,775 Dapagliflozin 10 mg tablets. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,077,688 tablets of the medication dapagliflozin 10 mg. The $5,948.05 firm fixed-price contract has an ultimate completion date of April 30, 2025 and is not a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...